Last reviewed · How we verify
Nautamine (etanautine)
Nautamine (generic name: etanautine) is a etanautine drug. It is currently in unknown development.
Etanautine works by blocking the action of acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine.
Nautamine, also known as etanautine, is a small molecule drug of the etanautine class. It was originally developed by a pharmaceutical company, but its current owner is unknown. The target of etanautine is not specified, and it is not FDA-approved for any indications. As a result, there is limited information available on its commercial status, safety considerations, or pharmacokinetic properties. Further research is needed to fully understand the characteristics and potential uses of etanautine.
At a glance
| Generic name | etanautine |
|---|---|
| Drug class | etanautine |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Think of acetylcholine like a messenger in your brain that helps you move and respond to the world around you. When acetylcholine is broken down too quickly, it can be hard to move or think clearly. Etanautine helps by slowing down the breakdown of acetylcholine, so it can do its job more effectively.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nautamine CI brief — competitive landscape report
- Nautamine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Nautamine
What is Nautamine?
How does Nautamine work?
What is the generic name of Nautamine?
What drug class is Nautamine in?
What development phase is Nautamine in?
Related
- Drug class: All etanautine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing